Filing metadata

Accession number
0001062993-21-004390
Form type
Form 4
Filer
Trillium Therapeutics Inc.
CIK
CIK 1616212
Filed
May 11, 2021
Reporting period
May 07, 2021
Description
Insider transaction

Explore SEC Filings Hub